Loading…
IceCure Medical Ltd is projected to rise to $0.2876 by 2027, a +28% move from its current price of $0.2253. ICCM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.2178 | $0.2254 | $0.2332 | +0.03% |
| May 30 | $0.2148 | $0.2254 | $0.2365 | +0.05% |
| May 31 | $0.2126 | $0.2255 | $0.2392 | +0.08% |
| Jun 1 | $0.2107 | $0.2255 | $0.2414 | +0.11% |
| Jun 2 | $0.2091 | $0.2256 | $0.2435 | +0.13% |
| Jun 3 | $0.2076 | $0.2257 | $0.2453 | +0.16% |
| Jun 4 | $0.2063 | $0.2257 | $0.247 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2063 | $0.2257 | $0.247 | +0.19% |
| Week 2 | $0.1991 | $0.2262 | $0.2569 | +0.38% |
| Week 3 | $0.1938 | $0.2266 | $0.2648 | +0.57% |
| Week 4 | $0.1896 | $0.227 | $0.2718 | +0.76% |
| Week 5 | $0.1859 | $0.2274 | $0.2782 | +0.95% |
| Week 6 | $0.1827 | $0.2279 | $0.2841 | +1.14% |
| Week 7 | $0.1799 | $0.2283 | $0.2897 | +1.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IceCure Medical Ltd is a commercial-stage medical device company that engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.
The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics.
IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd (ICCM) is a healthcare device maker with a current price of $0.235 and a market cap of $19.09M. It ranks 4959 by market capitalization.
The projected price path shows a neutral stance in 2026 and rising sentiment toward bullish, with average prices moving from $0.235 in 2026 to $0.8441 by 2050 and max values up to $1.74 in 2050, implying meaningful upside potential though not guaranteed.
Investors should note that these figures are forecasts and not guarantees, and actual results may vary over time.
A major floor 43.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.4% away) — a key level to hold.
The nearest ceiling, 61.1% above — a clean break opens room to run.
A major ceiling 224.0% above — clearing it would confirm fresh momentum.
Key ICCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2318 | Sell | $0.2296 | Sell |
| MA 10 | $0.2315 | Sell | $0.2349 | Sell |
| MA 20 | $0.2494 | Sell | $0.2545 | Sell |
| MA 50 | $0.3379 | Sell | $0.3367 | Sell |
| MA 100 | $0.4834 | Sell | $0.451 | Sell |
| MA 200 | $0.659 | Sell | $0.6041 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.13 | Neutral |
| Stoch RSI (14) | 63.69 | Neutral |
| CCI (20) | -78.59 | Neutral |
| Williams %R (14) | -83.33 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -6.25 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 16.67 | Buy |
| TRIX (15) | -1.70 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 35.23 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.23 | Sell |
| ADX (14) | 37.99 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is NEUTRAL with RSI(14) at 30. The SMA(50) is $0.3572 and the SMA(200) is $0.6653. Support is at $0.22 and resistance is at $0.363.
The 30-day price range runs from $0.1859 to $0.2971.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.22 | $0.2253 | $0.3328 | 0% | Neutral | |
| $0.2226 | $0.2876 | $0.3966 | +28% | Bullish | |
| $0.2148 | $0.2873 | $0.4136 | +28% | Bullish | |
| $0.2023 | $0.2786 | $0.4149 | +24% | Bullish | |
| $0.188 | $0.2658 | $0.4073 | +18% | Neutral | |
| $0.1911 | $0.2767 | $0.4346 | +23% | Bullish | |
| $0.1981 | $0.2935 | $0.4713 | +30% | Bullish | |
| $0.2293 | $0.347 | $0.5685 | +54% | Bullish | |
| $0.2463 | $0.3805 | $0.6349 | +69% | Bullish | |
| $0.2391 | $0.3767 | $0.6395 | +67% | Bullish | |
| $0.291 | $0.5019 | $0.915 | +123% | Bullish | |
| $0.3784 | $0.7669 | $1.55 | +240% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.22 | $0.2253 | $0.2675 | +0.00% |
| June 2026 | $0.20 | $0.2361 | $0.2863 | +4.80% |
| July 2026 | $0.1935 | $0.2309 | $0.2847 | -2.21% |
| August 2026 | $0.1932 | $0.2324 | $0.2903 | +0.66% |
| September 2026 | $0.2016 | $0.2443 | $0.3083 | +5.10% |
| October 2026 | $0.2023 | $0.2466 | $0.3141 | +0.94% |
| November 2026 | $0.1994 | $0.2444 | $0.3138 | -0.89% |
| December 2026 | $0.2086 | $0.2572 | $0.3328 | +5.22% |
Click any year to see its month-by-month ICCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ICCM price prediction for 2026 points to an average of $0.2253 (low $0.22, high $0.3328) — a potential gain of 0% on today's $0.2253. A consolidation phase looks the most probable path here.
In 2027, ICCM is projected to trade between $0.2226 and $0.3966, averaging $0.2876 — a potential gain of +28% from today's $0.2253. That is up +28% on the projected 2026 average. Momentum favours further upside here.
IceCure Medical Ltd's 2028 outlook centres on $0.2873, within a $0.2148 to $0.4136 range. That is 0% versus the projected 2027 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ICCM could reach as high as $0.4149, with a base case around $0.2786 and support toward $0.2023 — roughly +24% from $0.2253. Momentum favours further upside here.
Expect ICCM to range from $0.188 to $0.4073 through 2030. The $0.2658 average target implies a +18% move from current prices. That is -5% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The ICCM price prediction for 2031 points to an average of $0.2767 (low $0.1911, high $0.4346) — a potential gain of +23% on today's $0.2253. Momentum favours further upside here.
In 2032, ICCM is projected to trade between $0.1981 and $0.4713, averaging $0.2935 — a potential gain of +30% from today's $0.2253. That is up +6% on the projected 2031 average. Buyers look set to stay in control over this stretch.
IceCure Medical Ltd's 2033 outlook centres on $0.347, within a $0.2293 to $0.5685 range. That is up +18% on the projected 2032 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2034, ICCM could reach as high as $0.6349, with a base case around $0.3805 and support toward $0.2463 — roughly +69% from $0.2253. Buyers look set to stay in control over this stretch.
Expect ICCM to range from $0.2391 to $0.6395 through 2035. The $0.3767 average target implies a +67% move from current prices. That is -1% versus the projected 2034 average. Momentum favours further upside here.
The ICCM price prediction for 2040 points to an average of $0.5019 (low $0.291, high $0.915) — a potential gain of +123% on today's $0.2253. Buyers look set to stay in control over this stretch.
In 2050, ICCM is projected to trade between $0.3784 and $1.55, averaging $0.7669 — a potential gain of +240% from today's $0.2253. That is up +53% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ICCM today (≈ 4,438.526409 ICCM) could be worth
$3,403.76
+$2,403.76 (+240%) by 2050 · US Dollar
Based on the average projected ICCM price of $0.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICCMwould be worth at today's price.
$1,000 invested in ICCM on May 27, 2025 (≈ 884.955756 ICCM) would be worth
$199.38
-$800.62 (-80.1%) today · 0.20× · US Dollar
Based on a ICCM entry price of $1.13 vs. today's $0.2253.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.236 | $954.66 | -4.5% |
| 1 month ago | $0.284 | $793.31 | -20.7% |
| 3 months ago | $0.592 | $380.57 | -61.9% |
| 6 months ago | $0.722 | $312.05 | -68.8% |
| 1 year ago | $1.13 | $199.38 | -80.1% |
| All time (4.8y) ago | $10.9 | $20.67 | -97.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICCM forecast.
Our base-case forecast reaches $0.45 around 2040.
Implied market cap at $0.45: $36.56M
2030 forecast shows an average price of $0.2792 with a min of $0.1953 and a max of $0.4325, an ROI of 18.8%, and neutral sentiment.
2040 forecast shows an average price of $0.5487 with a max of $1.02, an ROI of 133.5%, and bullish sentiment.
2050 forecast shows an average price of $0.8441 with a max of $1.74, an ROI of 259.2%, and bullish sentiment.
These figures chart a path of rising prices and upside potential in later years, but forecasts are not guarantees and depend on various factors.
Tap a question to reveal the answer.
2030: average price $0.2792, min $0.1953, max $0.4325; ROI 18.8%; sentiment NEUTRAL.
The 2040 max price is $1.02 and the 2050 max price is $1.74, so a $1 target would fall within the forecasted range, with a projected max of $1.74 by 2050.
Current price is $0.235 and market cap is $19.09M.
Average price $0.3027, min $0.2329, max $0.4207; ROI 28.8%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising average prices and positive ROI (e.g., 2027 avg $0.3027, 2040 avg $0.5487, 2050 avg $0.8441). These figures are not guarantees and should be considered with other investment considerations.
IceCure Medical Ltd Community Discussion
0Share your IceCure Medical Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.